Today’s Top Story

Resolutions and Bylaws Committees to conduct open hearings this afternoon

The AAOS Resolutions and Bylaws Committees will conduct open hearings today regarding proposed resolutions and bylaw amendments for the American Academy of Orthopaedic Surgeons and the American Association of Orthopaedic Surgeons. Items being considered include 10 Academy or Association resolutions, as well as three sets of proposed bylaw amendments. The Resolutions Committee open hearing will take place Wednesday, March 7, at 1:00 p.m. in Room 347 of the Morial Convention Center. The Bylaws Committee open hearing will begin shortly after the conclusion of the Resolutions Committee meeting, at about 1:30 p.m.

Read more, including the list of discussion topics…

Other News

FDA announces recall of three lots of Hospira Hydromorphone HCl Injection

The U.S. Food and Drug Administration (FDA) states that Hospira, Inc. is voluntarily recalling three lots of Hydromorphone HCl Injection, USP CII 10 mg/mL, 1 mL in 2 mL Single Dose Vials. The company states that units from the lots may be empty or cracked at the bottom of the glass vial, compromising the sterility of the product. FDA states that providers and other organizations with an existing inventory of the lots subject to the recall should discontinue use and distribution of the remaining units and quarantine them immediately.

Read more…

FDA announces recall of ten lots of Sagent Methylprednisolone Sodium Succinate for Injection

FDA has announced a voluntary recall of ten lots of Methylprednisolone Sodium Succinate for Injection, USP, 40mg, 125mg, and 1g. The products were manufactured by Gland Pharma Ltd. and distributed by Sagent Pharmaceuticals. Sagent detected high out of specification impurity results during routine quality testing of stability samples for two lots. An elevated impurity has the potential to decrease effectiveness of the product in patients. Customers have been instructed to examine their inventory immediately and to quarantine, discontinue distribution of, and return the recalled lot of product.

Read more…

Study: Cobalt and chromium synovial fluid levels may help identify THA patients at risk of failure or ALTR

Assessment of synovial fluid levels for cobalt and chromium at the time of aspiration may help identify total hip arthroplasty (THA) patients who are most at risk for failure or adverse local tissue reaction (ALTR), according to Paper 853, presented yesterday at the AAOS Annual Meeting. Members of the research team prospectively collected synovial, blood, and serum samples from 58 revision THA patients, 29 of whom had an adverse reaction to metal debris (ARMD) and a matched cohort of 29 patients who underwent aseptic revision without ARMD. At time of revision, the researchers found that cobalt and chromium levels were significantly elevated in patients with an ARMD compared to those in the non-ARMD group. They also found that synovial fluid cobalt levels were an accurate test for detecting pseudotumor and ALTR.

Read more…

Study: Many CTR patients may prefer local anesthesia only

According to Scientific Paper 093, presented yesterday at the AAOS Annual Meeting, patients who undergo staged bilateral carpal tunnel release (CTR) may be equally satisfied with outcomes regardless of method of anesthesia. The researchers conducted a prospective, randomized, controlled trial of 48 patients aged 18 years or older who were scheduled to undergo staged bilateral CTR. Of 27 patients who completed the study, 26 (96 percent) reported they were equally satisfied with their outcome whether they were treated with local anesthesia only or local anesthesia plus sedation. However, the researchers found that wide-awake CTR with local-only anesthesia was preferred by 59 percent of patients, while sedation was preferred by 33 percent of patients.

Read more…


Last call: MACRA Episode-Based Cost Measures Clinical Subcommittee

AAOS seeks to nominate members to the MACRA Episode-Based Cost Measures Clinical Subcommittee, which will help develop care episode and patient condition groups for use in cost measures to meet the requirements of the Medicare Access and CHIP Reauthorization Act of 2015 (MACRA). Applicants for this position must be active fellows, candidate members, candidate members osteopathic, candidate member applicants for fellowship, or candidate member applicants for fellowship osteopathic. In addition, all applicants must provide the following: an online AAOS CAP application, a current curriculum vitae, a 100-word biography, and a letter of interest highlighting his or her expertise in the subject area. All supporting materials must be submitted to Kyle Trivedi by March 12, 2018, at 11:59 p.m. CT, at:

Learn more and submit your application…  (member login required)